Calcium acetate/magnesium carbonate: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
Tags: Reverted mobile edit mobile web edit
No edit summary
Tag: Manual revert
 
Line 2: Line 2:
{{stb}}
{{stb}}
{{No image}}
{{No image}}
__NOINDEX__

Latest revision as of 18:24, 18 March 2025

Calcium acetate/magnesium carbonate is a fixed-dose combination drug that contains 110 mg calcium and 60 mg magnesium ions and is indicated as a phosphate binder for dialysis patients suffering from hyperphosphataemia (abnormal high serum phosphorus levels). It is registered by Fresenius Medical Care under the trade names Renepho (Belgium) and OsvaRen (a number of other European countries)

This article is a stub.

You can help WikiMD by registering to expand it.
Editing is available only to registered and verified users.
WikiMD is a comprehensive, free health & wellness encyclopedia.